Wick Capital Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Wick Capital Partners's PFE Position: Q3 2026 in Review
Wick Capital Partners increased its Pfizer (PFE) stake by 101% in Q3 2026, buying an estimated $276K and bringing the position to 20,686 shares worth $590K. The position accounts for 0.07% of the portfolio, ranked #122.
Wick Capital Partners first reported a position in PFE in Q4 2021 and has held it in 4 quarters since. 2,886 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Wick Capital Partners held 20,686 shares of Pfizer worth $590K as of Q3 2026.
- Wick Capital Partners bought 10,369 Pfizer shares in Q3 2026, an estimated $276K.
- Pfizer made up 0.07% of Wick Capital Partners's portfolio in Q3 2026, its #122 holding.
- Wick Capital Partners first reported a position in Pfizer in Q4 2021 and has held it in 4 quarters since.
- 2,886 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Wick Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.